Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
5-Amino-1MQ is an experimental small molecule that blocks nicotinamide N-methyltransferase (NNMT), an enzyme tied to fat cell metabolism, NAD+ levels, and muscle function. Early animal and cell studies suggest it may reduce fat mass, improve insulin sensitivity, and support muscle regeneration, but no published human clinical trials have confirmed these effects, and it is not FDA approved for any use. It is often sold online or through compounding sources as a capsule or injectable, which raises real concerns about purity, dosing, and unknown long term risks. There are several important safety, legality, and efficacy factors to consider before anyone uses it, and they are explained in detail below.
If you are considering 5-Amino-1MQ because of weight gain, fatigue, stubborn belly fat, or low energy, it is worth first understanding what is actually driving those symptoms, since thyroid issues, insulin resistance, sleep disorders, and hormonal shifts can all produce the same complaints and each needs a different approach. A free, instant, online symptom check can help you organize what you are experiencing, see which conditions may explain it, and decide what type of clinician to talk to next instead of experimenting on yourself with an unproven compound.
Last reviewed for medical accuracy: 09/28/2026
5-Amino-1MQ (often written “5 amino 1mq”) is an experimental compound under investigation for its potential effects on metabolism, energy balance, and age-related health issues. Although still in early stages of research—primarily in cells and animal models—5-Amino-1MQ has attracted attention for its ability to influence a key enzyme involved in cellular energy regulation.
NNMT is an enzyme that modifies vitamin B3 (nicotinamide), affecting levels of NAD+—a molecule central to energy production, DNA repair, and cell health. By inhibiting NNMT, 5-Amino-1MQ may boost NAD+ availability, potentially improving metabolic function.
NNMT Inhibition
Impact on NAD+ Levels
Potential Downstream Effects
Metabolic Health
• Rodent models fed 5-Amino-1MQ showed reduced weight gain on high-fat diets.
• Improved insulin sensitivity and glucose tolerance were observed.
Energy Expenditure
• Treated mice exhibited higher resting metabolic rates.
• Increased activity of brown fat (energy-burning tissue) was noted.
Liver and Fat Tissue
• Lowered markers of fatty liver disease in animals.
• Decreased accumulation of triglycerides in fat cells.
Age-Related Benefits
• Some studies hint at better mitochondrial health in older animals.
• Possible reductions in markers of cellular senescence.
Because 5-Amino-1MQ is not approved by regulatory bodies like the FDA, all human use would be experimental. Anyone considering a research program should proceed only under professional supervision or within approved clinical trials.
Because of these unknowns, trying to self-administer 5-Amino-1MQ carries uncertainty. Always consult a qualified health professional before considering any experimental compound.
Experimental Status
Monitoring
Lifestyle First
If you’re experiencing symptoms like unexplained fatigue, rapid weight changes, or blood sugar fluctuations, it’s wise to explore underlying causes. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you identify possible concerns and guide your next steps.
5-Amino-1MQ shows promise in early studies as a compound that may enhance energy metabolism and support metabolic health by inhibiting NNMT and boosting NAD+ levels. However:
Before considering any experimental therapy, discuss potential benefits and risks with a qualified doctor. For life-threatening or serious concerns, always seek immediate medical attention.
Speak to a doctor about any health issues that could be serious or life-threatening.
(References)
* Akar S, Duran T, Azzawri AA, Koçak N, Çelik Ç, Yıldırım Hİ. Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells. J Obstet Gynaecol. 2021 Nov;41(8):1240-1245. doi: 10.1080/01443615.2020.1854696. Epub 2021 Mar 1. PMID: 33645410.
* Dimet-Wiley A, Wu Q, Wiley JT, Eswar A, Neelakantan H, Savidge T, Watowich S. Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice. Sci Rep. 2022 Jan 10;12(1):484. doi: 10.1038/s41598-021-03670-5. Epub 2022 Jan 10. PMID: 35013352; PMCID: PMC8748953.
* Yang M, Wang B, Hou W, Zeng H, He W, Zhang XK, Yan D, Yu H, Huang L, Pei L, Li K, Qin H, Lin T, Huang J. NAD(+) metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. J Immunother Cancer. 2024 Jul 27;12(7). doi: 10.1136/jitc-2024-009281. Epub 2024 Jul 27. PMID: 39067875; PMCID: PMC11284830.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.